[1] |
SHI Gexin, CHONG Rui, HE Kun, WU Haitang, ZHOU Yu, DUN Zhongjun, WEN Qing, ZHANG Jiguo, ZHANG Rong.
A fully replicated crossover bioequivalence study of mycophenolate mofetil capsules in Chinese healthy male subjects under fasting and fed conditions
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(11): 1255-1263.
|
[2] |
YAN Wenlong, SHU shuhua, LI Juan.
Effects of tight control of metabolic acidosis with 5% sodium bicarbonate on early renal function after living donor renal transplantation
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(10): 1139-1144.
|
[3] |
LU Xiaohong,WANG Peiguang.
Progress in the treatment of dermatomyositis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(7): 836-840.
|
[4] |
XIN Huawen, YANG Yan.
Association of synergistic effects of Wuzhi capsules on tacrolimus and PXR polymorphisms
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(10): 1138-1144.
|
[5] |
MA Xiao-qin, XIN Hua-wen, LI Yuan-qi, HUANG Hui, ZHAO Li, YU Ai-rong, LI Wei-liang, WU Xiao-chun.
Association of HGPRT activity and gene polymorphism with adverse reactions caused by azathioprine in kidney transplant recipients
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2015, 20(2): 182-187.
|
[6] |
XI Lan-yan YUAN Hong, CHENG Ke, ZHU Li-jun, YANG Guo-ping, ZHANG Gui-xiang, HUANG Zhi-jun.
Relationship between post-transplantation hypertension and dose, plasma concentration of tacrolimus
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2012, 17(1): 78-82.
|
[7] |
LI Qing, XIN Hua-wen, WU Xiao-chun, YU Ai-rong, XIONG Lei.
Clinical study for the effects of Wuzhi-capsule on blood concentration of tacrolimus in renal transplant recipients
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2009, 14(7): 804-807.
|
[8] |
HUANG Yun-jian, WANG Zi-hua, ZHANG Jing-bo, CHEN Feng, ZHAO Jing-hong.
Therapeutic effects of mycophenolate mofetil in refractory nephrotic syndrome
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2009, 14(2): 186-190.
|
[9] |
WU Xiao-chun, XIONG Hui, XIONG Lei, SU Dan, XIN Hua-wen, LI Qing.
Research on the relationship between thiopurine S-methyltransferase genetic polymorphisms and azathioprine adverse drug reactions in patients with kidney transplantation
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2008, 13(9): 1037-1043.
|
[10] |
YU Ai-rong, XIN Hua-wen, WU Xiao-chun. Li Qing.
A cical study on codirtiono of Cyloporin A and beberin hydro-chlride in renal transplanted recipients
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2007, 12(12): 1415-1418.
|
[11] |
XIN Hua-wen, FISCHER Christine, SCHWAB Matthias, KLOTZ Ulrich.
Effects of furosemide, piretanide and azathioprine on thiopurine methyltransferase activity in red blood cells from patients with chronic inflammatory bowel disease
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2005, 10(6): 655-658.
|
[12] |
YU Tang-Hong, JIA Ru-Han, DING Guo-Hua, XIONG Yan, CHEN Jian.
Protective effects of mycophenolate mofetil on kidneys of type 2 diabetic rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2004, 9(10): 1119-1122.
|
[13] |
DONG Ya-Lin, WANG Mao-Yi, HUANG Meng, TIAN Pu-Xun, PANG Sheng-Qiang.
Clinical use of mycophenolate mofetil in renal taransplation
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 1999, 4(4): 313-315.
|
[14] |
Xu Feng, Wu Zhaohui, Zhang Zhongyi, Zou Hengqing.
Concentration-dependent effect of cyclosporine on plasma lipid in renal transplant recipients
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 1997, 2(3): 165-168.
|